
The GCSA certification is the world’s only internationally recognised global quality standard for clinical trial sites, focusing on the business operations that support high-quality research delivery. Developed in response to industry demand, the GCSA certification for clinical research sites provides a clear symbol of excellence and identifies a site as a trusted global partner for sponsors, CROs, and participants.
Through a structured and supportive certification journey, GCSA site certification, helps sites embed internationally recognised best practice aligned with modern ICH-GCP principles, build consistent, scalable operational processes, strengthen inspection and audit readiness, evidence quality and demonstrate commitment to continual improvement.
The GCSA clinical trial site certification journey assesses 7 high-impact areas that are recognized by the industry, as essential for delivering high-quality studies.
Feasibility
Study Start-Up and Initiation
Participant Engagement
Study Management, Operations and Close Down
Workforce Quality
Growth and Strategy
Governance and Leadership

Your Roadmap to Clinical Trial Site Excellence and Enhanced International Visibility
The structured GCSA certification journey, guides sites through evidence collection, independent review, assessment , and gap analysis, leading to a tailored action plan that strengthens global best-practice processes.
This study site certification improves efficiency, builds capacity, and supports scalable growth. It also enhances credibility and international recognition. Upon achieving GCSA Certification, organisations benefit from ongoing recognition and promotional support from IAOCR, helping to raise the profile of certified research sites across the global clinical research community. Certified organisations are also provided opportunities to engage with sponsors, CROs and peer research sites through IAOCR-led initiatives, supporting visibility, collaboration and continued organisational development.
GCSA Certification Enables:
GCSA certification enables:
Formal demonstration of quality and excellence
Improved confidence for participants, sponsors/CROs, and staff
Enhanced leverage for business development activities to support the attraction of commercial research opportunities
Optimized business operational processes that improve efficiency and capacity
Readiness for scalable and sustainable growth
International recognition as a ‘Trusted Global Partner’ in clinical research
Representation on the IAOCR Global Best Practices Board

The GCSA Standard was developed by IAOCR in response to increasing demand from sponsors, CROs and the wider clinical research community for greater organisational capability, operational excellence and consistent quality across clinical research sites.
Developed to address key industry challenges, GCSA provides an internationally recognised framework that helps research organisations strengthen governance, improve operational performance, foster more effective collaboration with sponsors and CROs, and ultimately enhance the participant experience.
The GCSA Standard was developed over a four-year period through extensive consultation with IAOCR's Global Advisory Board and other international stakeholders, including sponsors, CROs, clinical research sites, academic institutions and government organisations. The result is an evidence-based certification framework that reflects global best practice and the evolving expectations of modern clinical research. GCSA Certification assures sponsors and CROs of a site’s capability, validated through independent assessment against sponsor-defined quality standards and expectations relating to 7 critical business operational areas that underpin the delivery of world-class clinical trials.The GCSA Quality Mark identifies organisations as Trusted Global Partners, providing a recognised symbol of organisational excellence that inspires confidence among sponsors, CROs and research partners. It offers certified sites a clear competitive differentiator while demonstrating a commitment to quality, capability and continuous improvement.
“As a sponsor of dermatology trials, the GCSA certification standard gives me confidence that sites are working to a global quality standard and have been independently audited by IAOCR. When a site is GCSA Certified I have confidence that they will be a high-quality partner for our clinical trials.”
Dr Sam Kerr
Global Sponsor
Chief Scientific Officer
“As a board member for the GCSA Global Advisory Board, it is possible to see the difference that this certification for the global quality standard for sites will make to the ongoing delivery of clinical trials in our ever-challenging environment. The benefits of the certification include transparency for both sites and sponsors, enabling reassurance and trust in the commitment to the delivery of the highest quality research and facilitation of true synergistic partnerships across the clinical trial landscape.”
Fiona Shields
Global Sponsor
Study and Site Operations Country Head
Our comprehensive, evidence-based certification process supports organisations conducting clinical research across a wide range of settings worldwide, including hospitals, healthcare organisations, NHS providers, commercial research sites, academic institutions and integrated research networks, by:
Demonstrating quality and organisational capability – provides independent evidence of excellence and builds confidence among sponsors, CROs, regulators and participants.
Embedding best-practice processes aligned with ICH GCP E6(R3) – strengthens governance, consistency and quality by integrating internationally recognised good clinical practice principles throughout the organisation.
Streamlining and optimising business operations – improves efficiency, enhances participant safety and reduces operational risk.
Strengthening governance and organisational systems – establishes robust, sustainable processes that drive consistency, accountability and continuous improvement.
Maximising participant engagement – supports the attraction, recruitment and retention of clinical trial participants through participant-centred practices.
Enhancing feasibility and study start-up – improves study readiness, accelerates activation and supports timely recruitment.
Driving effective study management – enables consistent, high-quality study delivery from feasibility through to close-out.
Strengthening workforce capability and process quality – supports competent, engaged and valued teams, fostering professional development, staff retention and a culture of continuous improvement.


“We take what we do very seriously, because of the impact our trials can have on our patients and their families. We wanted to ensure we were providing the best quality service to our patients, their families, the Sponsors and CRO clients, whilst also developing our team. Through the independent GCSA assessment, we have been able to demonstrate and embed best practices and processes.”
Vicky Eyre
Re: Cognition Health (UK)
Director of UK Clinical Trials
Full case study: Re: Cognition Health
“At AGA Clinical Trials, we are dedicated to demonstrating how we are a global center of excellence and the GCSA and IAOCR certifications were the logical next steps for us to achieve our mission of improving health and quality of life for our patients. The GCSA and subsequent IAOCR certification processes were in-depth and detailed, which allowed our team to reflect on our working processes beyond the core assessment. We’re delighted with the results because we are truly committed to working to the highest Industry standards.”
Dr. Maria Graber
AGA Clinical Trials
CEO
Press Release: AGA Clinical Trials (US)“The GCSA certification process offered more than just validation – it was a true opportunity for reflection and growth. It enabled us to celebrate areas of strength whilst also identifying opportunities to further refine and enhance our processes. The Certification reinforces the credibility and quality of our research operations through independent external review. Ultimately, it supports our continued commitment to delivering high-quality experiences for both patients and sponsors.”
Sophie Mepham
ICON Group
Executive Manager for Research
Press Release: ICON Group (Australia)Comprehensive organisational assessment – gain an in-depth, independent evaluation of your organisation's capability, governance, operational maturity and readiness to deliver high-quality clinical research.
Evidence-based gap analysis – receive a detailed assessment identifying organisational strengths, opportunities for improvement and practical recommendations aligned with international best practice and ICH GCP E6(R3).
Actionable roadmap for continuous improvement – benefit from tailored recommendations that support sustainable process excellence, stronger governance and long-term organisational capability.
Independent international recognition – achieve the prestigious GCSA Quality Mark, demonstrating your organisation's commitment to quality, operational excellence and continuous improvement as a Trusted Global Clinical Research Partner.
Enhanced sponsor and CRO confidence – provide independent evidence of organisational capability, helping differentiate your organisation during site selection and partnership discussions.
Ongoing quality assurance – maintain certification through regular surveillance and reassessment, demonstrating a sustained commitment to continuous improvement rather than a one-time achievement.
Global recognition and promotional support – following certification, IAOCR helps raise the profile of certified organisations through international marketing, case studies, announcements and other promotional opportunities.
Access to a global community of excellence – join an international network of GCSA Certified organisations, sharing knowledge, best practices and experiences with peers committed to advancing clinical research quality.
Opportunities to shape the future of clinical research – opportunities to contribute to IAOCR working groups, Think Tank events and the Global Best Practices Board, collaborating alongside sponsors, CROs and fellow certified organisations to influence emerging best practice across the industry.









